Concept Stage

Not decided on lead clinical application or target patient group

Often there are multiple potential applications for an innovation. The choice of lead indication is a crucial on for the technology and the company.

ASSESS supports innovators in understanding the net value of each potential application, considering issues like the scope for improving health outcomes and health system efficiency, and likelihood of patient and care provider adoption.

Objectives Clinical conditions Stages of clinical conditions Care contexts End users
Learn more
team
How We Do It

Analytic approach to informing foundational decisions

At each stage of the Commercialization Journey, life sciences innovators have key questions, and analytic and decision support needs, that can be answered and provided by those with expertise in health technology assessment and health economics.

team
Photo by Stefan Cosma on Unsplash

Stage based insights and methods

Insights help to inform strategy and focus evidence generation activities on those that are the most valuable, and analyses and evidence generated support communication with investors, end users and payers.

ASSESS and a global network of experts bring methods and insights from health technology assessment and economic modelling to help innovative companies make informed strategic decisions early in technology development. Innovators at the Concept Stage can have decisions informed by Clinical Application Identification analysis.

  • Trial Objectives
  • Implementation Strategies
  • Study Design
  • Outcome Measures

Clinical Application Evaluation

Early-stage innovators often have a number of options with respect to the choice of beachhead clinical application of new technology.

Early value assessment analysis informs this critical foundational decision-making early in technology development, supporting innovators to make strategic choices that maximize technology commercial potential and probability of success.

Clinical application options
Target care context Providers End users Patient groups Clinical concerns
Clinical and economic value targets
Regulators Payers Clinicians Patients
View Case Study
Scope and Approach Clinical Data Intended Purpose and Application
team
Photo by CHUTTERSNAP on Unsplash
Testimonials

What our clients say

Proton

“We enjoyed working with and recommend ASSESS. They helped us to complete an early economic analysis, including a variety of sensitivity analyses, to assist us to demonstrate that our product is extremely cost effective in our target population.”

Rory St. Clair
VP Operations
Careteam

“We are extremely satisfied with the work done and have already recommended the service to others.

This program has been invaluable to us, I can't say enough to recommend it - this kind of evidence is vital to digital health sales and incredibly hard to find. We plan to include the service in major research projects in the future to demonstrate the economic impact of our interventions.”

Rob Attwell
COO
Nura Medical

“The ASSESS project provided NURA with robust, real-world data to substantiate the health economic rationale underlying our pricing structure. This data will be instrumental in presenting our value proposition to hospital decision-makers and investors.”

Georgia Powell
Co-founder & CEO
Greenspace

“Our team was very happy with the level of thoroughness and rigor of the work and deliverables from the ASSESS team, as well as their communication. We would recommend the service to other organizations given the ease of working with the ASSESS team and the rigor of their work.”

Tanya Scarapicchia

Contact Us

Contact us to learn more about how insights from ASSESS can help your organization make informed strategic decisions that help maximize commercial success of technology in development.

Let's talk